Cite
HARVARD Citation
Lila, A. et al. (n.d.). THU0193 Efficacy and safety of bcd-055 (INFLIXIMAB BIOSIMILAR) in rheumatoid arthritis. results of bcd-055–3/lira phase 3 clinical study. Annals of the rheumatic diseases. pp. 316-317. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lila, A. et al. (n.d.). THU0193 Efficacy and safety of bcd-055 (INFLIXIMAB BIOSIMILAR) in rheumatoid arthritis. results of bcd-055–3/lira phase 3 clinical study. Annals of the rheumatic diseases. pp. 316-317. [Online].